Phase III trial of ELND 005 in patients with Alzheimer's disease.
Phase of Trial: Phase III
Latest Information Update: 10 May 2011
At a glance
- Drugs ELND 005 (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 10 May 2011 This trial is still in the planning stages.
- 11 Aug 2010 New trial record